Relmada Therapeutics Inc.
Organization details
- Legal name
- Relmada Therapeutics Inc.
- Former names
- Camp Nine, INC.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Coral Gables
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- RLMD
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001553643
- EIN
- 45-5401931
Board of directors
-
Charles J. Casamento · DirectorSince 2023
-
Eric Thomas Schmidt · DirectorSince 2023
-
Fabiana Fedeli · DirectorSince 2023
-
John Glasspool · DirectorSince 2023
-
Paul Edward Kelly · Director · COOSince 2023
-
Sergio Traversa · Director · Chief Executive OfficerSince 2023
Chief executives
Board connections
2 of this board's directors also sit on 4 other boards. 3 are in the same sector.
-
Eton Pharmaceuticals Inc. Same sectorvia Charles J. Casamento
-
GT Biopharma Inc. Same sectorvia Charles J. Casamento
- via Charles J. Casamento
-
Revolution Medicines Inc. Same sectorvia Eric Thomas Schmidt
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $1,833,350
- 6 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +100,000 | $4.10 | $410,000 |
| Sep 10, 2026 | Shenouda Maged Officer (Chief Financial Officer) | Open-market purchase | +79,800 | $4.25 | $339,150 |
| Sep 9, 2026 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +100,000 | $4.18 | $418,000 |
| Sep 9, 2026 | Shenouda Maged Officer (Chief Financial Officer) | Open-market purchase | +120,200 | $4.20 | $504,840 |
| Dec 15, 2025 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +27,500 | $4.12 | $113,300 |
| Dec 15, 2025 | Shenouda Maged Officer (Chief Financial Officer) | Open-market purchase | +11,665 | $4.12 | $48,060 |
| Nov 5, 2025 | Ence Chuck Officer (CAO and COO) | Open-market purchase | +136,000 | $2.20 | $299,200 |
| Nov 5, 2025 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +272,500 | $2.20 | $599,500 |
| Nov 5, 2025 | Shenouda Maged Officer (Chief Financial Officer) | Open-market purchase | +500,000 | $2.20 | $1,100,000 |
| Nov 5, 2025 | Paul Edward Kelly Director, Officer (Chief Operating Officer) | Open-market purchase | +90,000 | $2.20 | $198,000 |
| Aug 28, 2025 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +55,976 | $0.74 | $41,422 |
| Aug 27, 2025 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +129,455 | $0.67 | $86,735 |
| Aug 26, 2025 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +80,545 | $0.62 | $49,938 |
| May 20, 2025 | Shenouda Maged Officer (Chief Financial Officer) | Open-market purchase | +60,000 | $0.52 | $31,200 |
| May 20, 2025 | Sergio Traversa Director, Officer (Chief Executive Officer) | Open-market purchase | +147,686 | $0.56 | $82,704 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Relmada Therapeutics Inc.
Who is the CEO of Relmada Therapeutics Inc.?
Sergio Traversa is Relmada Therapeutics Inc.'s CEO.
How many directors are on Relmada Therapeutics Inc.'s board?
Relmada Therapeutics Inc.'s board has 6 directors: Charles J. Casamento, Eric Thomas Schmidt, Fabiana Fedeli, John Glasspool, Paul Edward Kelly and Sergio Traversa.
Are Relmada Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Relmada Therapeutics Inc. insiders bought $1.8 million of shares in 6 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="relmada-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.